129 related articles for article (PubMed ID: 22932077)
1. Loss of membranous carcinoembryonic antigen-related cell adhesion molecule 1 expression is related to decreased relapse-free survival of hepatocellular carcinoma following liver transplantation.
Sha QQ; Wei QZ; Zhu JK; Wang KX; Wang C; Liu HT; Yu WB; Li MX; Zhang GY
Chin Med J (Engl); 2012 Aug; 125(16):2841-5. PubMed ID: 22932077
[TBL] [Abstract][Full Text] [Related]
2. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma.
Cruz PV; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K
Cancer; 2005 Jul; 104(2):354-60. PubMed ID: 15952183
[TBL] [Abstract][Full Text] [Related]
3. CEACAM1 cytoplastic expression is closely related to tumor angiogenesis and poorer relapse-free survival after curative resection of hepatocellular carcinoma.
Zhu J; Yang Y; Ma C; Zhang G; Wang K; Hu S
World J Surg; 2011 Oct; 35(10):2259-65. PubMed ID: 21519971
[TBL] [Abstract][Full Text] [Related]
4. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
[TBL] [Abstract][Full Text] [Related]
5. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
[TBL] [Abstract][Full Text] [Related]
8. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
11. Fascin expression in progression and prognosis of hepatocellular carcinoma.
Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
[TBL] [Abstract][Full Text] [Related]
12. Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
Yoshikawa M; Morine Y; Ikemoto T; Imura S; Higashijima J; Iwahashi S; Saito YU; Takasu C; Yamada S; Ishikawa D; Teraoku H; Takata A; Yoshimoto T; Shimada M
Anticancer Res; 2017 Mar; 37(3):1169-1175. PubMed ID: 28314278
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions.
Liu JN; Shang Guan YM; Qi YZ; Wang HB; Zhang TG; Zhou CJ
Ann Diagn Pathol; 2012 Aug; 16(4):235-44. PubMed ID: 22209504
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
Levi DM; Tzakis AG; Martin P; Nishida S; Island E; Moon J; Selvaggi G; Tekin A; Madrazo BL; Narayanan G; Garcia MT; Feun LG; Tryphonopoulos P; Skartsis N; Livingstone AS
J Am Coll Surg; 2010 May; 210(5):727-34, 735-6. PubMed ID: 20421039
[TBL] [Abstract][Full Text] [Related]
15. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
16. Levels of HBx, VEGF, and CEACAM1 in HBV-related hepatocellular carcinoma and their correlation with cancer prognosis.
Mao CS; Yin H; Ning HB; Peng Z; Li K; Ding GQ
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3827-3833. PubMed ID: 28975984
[TBL] [Abstract][Full Text] [Related]
17. [Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].
Zheng SS; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Wu J; Lu AW; Shao ZX
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):450-4. PubMed ID: 15854372
[TBL] [Abstract][Full Text] [Related]
18. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of CEACAM1 and HBx in HBV related hepatocellular carcinoma].
Liu KG; Xu GZ; Yao Y; Wu W; Li YJ; Ren TT; Xu GH; Ye L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):410-2. PubMed ID: 22482415
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]